3PU-23488-67041 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-10
Registered in v-safe
2021-04-10
Dose 1 — Pfizer-BioNTech
2021-04-10
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-11
Survey response — days 1–6 daily, dose 1
MedDRA: Injection site bruising — Feeling: Good · Site: Swelling · Fatigue or tiredness

Free text: Bruise at injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Diarrhea

Adult check-in
2021-04-13
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-05-01
Dose 2 — Pfizer-BioNTech
2021-06-12
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-31
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-30
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-05-05
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-10	Pfizer-BioNTech
2	2021-05-01	Pfizer-BioNTech

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-11

Systemic reaction (other): Bruise at injection site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Injection site bruising	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release